Subscribers will be able to compare medications through Amazon and pay either their insurance copay price or the price from Prime Therapeutics’ MedsYourWay discount card.
Florida Blue will offer Amazon Pharmacy as their home delivery service provider for its commercial insured members. Starting Jan. 1, 2023, more than 2 million Florida Blue members covered under individual and employer group insured products, including Truli for Health, a Florida Blue-affiliated health plan, will have access to Amazon Pharmacy’s prescription medications. Earlier this year, Florida Blue also began making the service available to self-insured employers.
Florida Blue, Florida’s Blue Cross and Blue Shield company, serves more than 6 million members across the state. Florida Blue contracts with Prime Therapeutics to provide pharmacy benefit management and home delivery services. Amazon Pharmacy, launched in November 2020, offers medications that treat common conditions such as high blood pressure, high cholesterol, diabetes, and depression.
“Florida Blue hopes the savings and the familiarity of ordering through Amazon will make it easier for our members to get their daily medications and better manage their health,” Chuck Divita, Florida Blue executive vice president of commercial markets, said in a press release. “By selecting Amazon Pharmacy as our exclusive home delivery provider, we aim to provide our members with a more cost-effective and simplified way to get the medications they need to support their health.”
Amazon Pharmacy includes transparent, real-time pricing information and allows users to compare and choose either their insurance copay price or the price from Prime Therapeutics’ MedsYourWay discount card. Prime launched the discount card in October 2021 to offer the Amazon Pharmacy option to Blues’ members.
Related: Prime Therapeutics Offers Home Delivery Using Amazon Pharmacy
For Florida Blue subscribers, all covered and eligible drug purchases, whether using the copay or discount card pricing, may count toward out-of-pocket maximums and deductibles.
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More